Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities
Yue Su, Ridong Li, Xianling Ning, et al.
European Journal of Medicinal Chemistry (2019) Vol. 177, pp. 32-46
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu, Haiying Sun
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14382-14403
Closed Access | Times Cited: 71
The revival of dithiocarbamates: from pesticides to innovative medical treatments
Laurine Kaul, Regine Süss, Andrew C.W. Zannettino, et al.
iScience (2021) Vol. 24, Iss. 2, pp. 102092-102092
Open Access | Times Cited: 62
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Xiaojing Pang, Xiujuan Liu, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4250-4250
Open Access | Times Cited: 57
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 8
An insight into medicinal attributes of dithiocarbamates: Bird’s eye view
Sangita Dattatray Shinde, Akash P. Sakla, Nagula Shankaraiah
Bioorganic Chemistry (2020) Vol. 105, pp. 104346-104346
Closed Access | Times Cited: 65
The Development of BTK Inhibitors: A Five-Year Update
Bruno Tasso, Andrea Spallarossa, Eleonora Russo, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7411-7411
Open Access | Times Cited: 48
Transition‐Metal‐Free C(sp2)‐H Dithiocarbamation and Chromone Annulation Cascade for 3‐Dithiocarbamyl Chromone Synthesis
Tao Zhang, Weijun Yao, Jie‐Ping Wan, et al.
Advanced Synthesis & Catalysis (2021) Vol. 363, Iss. 20, pp. 4811-4816
Closed Access | Times Cited: 43
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 33
Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors
Ruifeng Wang, Sijia Yu, Xiangxin Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 188, pp. 112024-112024
Closed Access | Times Cited: 46
Synthesis of N-2(5H)-furanonyl sulfonyl hydrazone derivatives and their biological evaluation in vitro and in vivo activity against MCF-7 breast cancer cells
Kai Yang, Jianqiong Yang, Shi‐He Luo, et al.
Bioorganic Chemistry (2020) Vol. 107, pp. 104518-104518
Closed Access | Times Cited: 45
Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors
Akshita Chauhan, Tabassum Khan
Chemical Biology & Drug Design (2020) Vol. 97, Iss. 3, pp. 774-794
Closed Access | Times Cited: 35
Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents
Ruifeng Wang, Yixuan Chen, Xiangxin Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111716-111716
Closed Access | Times Cited: 32
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
FAK inhibitors in cancer, a patent review – an update on progress
Ya‐Xi Ye, Yuyao Cao, Lisheng Xu, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 593-610
Closed Access | Times Cited: 2
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study
Ruifeng Wang, Xiangxin Zhao, Sijia Yu, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104092-104092
Closed Access | Times Cited: 25
An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents
Isha Rani, Navgeet Kaur, Anju Goyal, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 5, pp. 525-561
Closed Access | Times Cited: 13
Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Shenxin Zeng, Shuai Yuan, Yu Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106713-106713
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
Yang Liu, Lijun Kong, Na Li, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106895-106895
Closed Access | Times Cited: 7
FAK Inhibitors As Promising Anticancer Targets: Present and Future Directions
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia A Abdelhafeez, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 18, pp. 1559-1590
Open Access | Times Cited: 15
Screening assays for tyrosine kinase inhibitors: A review
Juan Gao, Jingyi Jian, Zhengjin Jiang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 223, pp. 115166-115166
Open Access | Times Cited: 11
Design, Synthesis, Biological Evaluation, and Molecular Docking of 2,4-Diaminopyrimidine Derivatives Targeting Focal Adhesion Kinase as Tumor Radiotracers
Yueheng Qi, Ye Li, Yu Fang, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 4, pp. 1634-1642
Closed Access | Times Cited: 14
Design, synthesis and biological evaluation of novel FAK inhibitors with better selectivity over IR than TAE226
Tao Chen, Yan Liu, Jiang Liu, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105790-105790
Closed Access | Times Cited: 10
Spatial organization of PI3K-PI(3,4,5)P3-AKT signaling by focal adhesions
Jing Wang, Zhengyang An, Zhongsheng Wu, et al.
Molecular Cell (2024) Vol. 84, Iss. 22, pp. 4401-4418.e9
Open Access | Times Cited: 1
New Insights on Fak and Fak Inhibitors
Chiara Brullo, Bruno Tasso
Current Medicinal Chemistry (2020) Vol. 28, Iss. 17, pp. 3318-3338
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top